1. Home
  2. POAI vs GSIW Comparison

POAI vs GSIW Comparison

Compare POAI & GSIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • POAI
  • GSIW
  • Stock Information
  • Founded
  • POAI 2002
  • GSIW 2016
  • Country
  • POAI United States
  • GSIW Hong Kong
  • Employees
  • POAI N/A
  • GSIW N/A
  • Industry
  • POAI Industrial Specialties
  • GSIW
  • Sector
  • POAI Health Care
  • GSIW
  • Exchange
  • POAI Nasdaq
  • GSIW Nasdaq
  • Market Cap
  • POAI 7.8M
  • GSIW 8.1M
  • IPO Year
  • POAI N/A
  • GSIW 2023
  • Fundamental
  • Price
  • POAI $14.77
  • GSIW $0.18
  • Analyst Decision
  • POAI Hold
  • GSIW
  • Analyst Count
  • POAI 1
  • GSIW 0
  • Target Price
  • POAI N/A
  • GSIW N/A
  • AVG Volume (30 Days)
  • POAI 230.9K
  • GSIW 13.8M
  • Earning Date
  • POAI 11-11-2025
  • GSIW 01-01-0001
  • Dividend Yield
  • POAI N/A
  • GSIW N/A
  • EPS Growth
  • POAI N/A
  • GSIW N/A
  • EPS
  • POAI N/A
  • GSIW N/A
  • Revenue
  • POAI $1,664,696.00
  • GSIW $5,368,221.00
  • Revenue This Year
  • POAI $486.27
  • GSIW N/A
  • Revenue Next Year
  • POAI $65.50
  • GSIW N/A
  • P/E Ratio
  • POAI N/A
  • GSIW N/A
  • Revenue Growth
  • POAI 71.65
  • GSIW 283.23
  • 52 Week Low
  • POAI $8.25
  • GSIW $0.09
  • 52 Week High
  • POAI $45.90
  • GSIW $2.59
  • Technical
  • Relative Strength Index (RSI)
  • POAI 78.34
  • GSIW 54.81
  • Support Level
  • POAI $12.15
  • GSIW $0.14
  • Resistance Level
  • POAI $15.15
  • GSIW $0.16
  • Average True Range (ATR)
  • POAI 1.98
  • GSIW 0.02
  • MACD
  • POAI 1.19
  • GSIW 0.01
  • Stochastic Oscillator
  • POAI 45.66
  • GSIW 91.84

About POAI Predictive Oncology Inc.

Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.

About GSIW Garden Stage Limited

Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: a) I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong, and b) I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.

Share on Social Networks: